[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100519203":3},{"organization":4,"armGroups":7,"interventions":26,"overallOfficials":11,"centralContacts":40,"locations":49,"responsibleParty":66,"collaborators":11,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":72,"acronym":11,"eligibilityCriteria":73,"healthyVolunteers":70,"sex":74,"minAge":75,"maxAge":11,"enrollmentInfo":76,"targetDuration":11,"studyType":79,"phases":80,"briefSummary":83,"conditions":84,"keywords":87,"overallStatus":52,"whyStopped":11,"lastUpdateSubmitDate":94,"lastUpdatePostDateStruct":95,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":103},{"fullName":5,"class":6},"University of Brasilia","OTHER",[8,15,18,23],{"label":9,"type":10,"description":11,"interventionNames":12},"Oral Miltefosine and Pentoxifylline for Cutaneous Leishmaniasis","EXPERIMENTAL",null,[13,14],"Drug: Miltefosine 50mg","Drug: Pentoxifylline 400mg",{"label":16,"type":10,"description":11,"interventionNames":17},"Oral Miltefosine and Pentoxifylline for Mucous Leishmaniasis",[13,14],{"label":19,"type":20,"description":11,"interventionNames":21},"Intravenous Liposomal Amphotericin B for Cutaneous Leishmaniasis","ACTIVE_COMPARATOR",[22],"Drug: Liposomal Amphotericin B",{"label":24,"type":20,"description":11,"interventionNames":25},"Intravenous Liposomal Amphotericin B for Mucous Leishmaniasis",[22],[27,32,36],{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":11},"DRUG","Miltefosine 50mg","Oral Miltefosine 50mg bid",[9,16],{"type":28,"name":33,"description":34,"armGroupLabels":35,"otherNames":11},"Pentoxifylline 400mg","Oral Pentoxifylline 400mg tid",[9,16],{"type":28,"name":37,"description":38,"armGroupLabels":39,"otherNames":11},"Liposomal Amphotericin B","Intravenous 25 to 40mg\u002Fkg",[19,24],[41,46],{"name":42,"role":43,"phone":44,"phoneExt":11,"email":45},"Raimunda Sampaio, PhD","CONTACT","+556120285415","rnrsampaio@hotmail.com",{"name":47,"role":43,"phone":44,"phoneExt":11,"email":48},"Sofia Martins, PhD","sofiasalesm@gmail.com",[50],{"facility":51,"status":52,"city":53,"state":54,"zip":55,"country":56,"countryCode":57,"cosmosGeoPoint":58,"geoPoint":63,"contacts":64},"Hospital Universitario de Brasilia","RECRUITING","Brasília","Federal District","70840-901","Brazil","BR",{"type":59,"coordinates":60},"Point",[61,62],-47.92972,-15.77972,{"lat":62,"lon":61},[65],{"name":42,"role":43,"phone":44,"phoneExt":11,"email":45},{"type":67,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100519203","phase-2-pilot-study-oral-treatment-of-american-tegumentary-leishmaniasis-cutaneous-and-mucosal-forms-in-the-elderly-100519203",false,"NCT06040489","Pilot Study: Oral Treatment of American Tegumentary Leishmaniasis (Cutaneous and Mucosal Forms) in the Elderly","Inclusion Criteria:\n\n* Active confirmed cutaneous leishmaniasis ou mucosal leishmaniasis\n* Use of highly effective contraceptive method and a negative serologic pregnancy test (beta - HCG), if female in fertile phase\n* Agree and sing informed consent form\n\nExclusion Criteria:\n\n* Previous treatment with leishmanicidal drugs in the last 6 months\n* Pre-treatment electrocardiographic changes that contraindicate the use of liposomal amphotericin B (QTc greater than 450ms)\n* Serum creatinine or urea 1.5 times the upper limit of normal\n* Patients with severe or decompensated liver, kidney, heart disease, Diabetes Mellitus\n* history of any hypersensitivity reaction to liposomal amphotericin B, miltefosine and\u002For pentoxifylline\n* Pregnant and breastfeeding women\n* Patients with Acquired Immunodeficiency Syndrome (AIDS) or other immunodeficiency","ALL","50 Years",{"count":77,"type":78},100,"ESTIMATED","INTERVENTIONAL",[81,82],"PHASE2","PHASE3","Randomised clinical trial comparing oral miltefosine associated with pentoxifylline to intravenous liposomal amphotericin b for the treatment of cutaneous and mucosal leishmaniasis",[85,86],"Leishmaniasis; Brazilian","Leishmaniasis, Mucocutaneous",[88,89,90,91,92,93],"Elderly","Miltefosine","Leishmaniasis","Pentoxifylline","Liposomal amphotericin b","Treatment","2023-09-13",{"date":96,"type":97},"2023-09-15","ACTUAL",{"date":99,"type":97},"2022-06-22",{"date":101,"type":78},"2026-06",{"name":5,"class":6},1]